Valeo Financial Advisors
RDY icon

Valeo Financial Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Valeo Financial Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$6K – 1513
2021
Q1 		$6K Hold
500
– – ﹤0.01% 1523
2020
Q4 		$7K Hold
500
– – ﹤0.01% 1291
2020
Q3 		$7K Buy
+500
New +$5.96K ﹤0.01% 1172
2018
Q4 		– Sell
-90
Closed -$1K – 1684
2018
Q3 		$1K Buy
+90
New +$601 ﹤0.01% 1669

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Valeo Financial Advisors's RDY Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2021, closing a stake of 500 shares — an estimated $6K sold.

Valeo Financial Advisors first reported a position in RDY in Q3 2018 and held it in 4 quarters. The position peaked at $7K in Q4 2020. 161 funds tracked by Wall St. Rank hold RDY as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 500 Dr. Reddy's Laboratories shares in Q2 2021, an estimated $6K.
  • Valeo Financial Advisors first reported a position in Dr. Reddy's Laboratories in Q3 2018 and held it in 4 quarters.
  • Valeo Financial Advisors's Dr. Reddy's Laboratories position peaked at $7K in Q4 2020.
  • 161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.